Global Eagle Entrtn (ENT) Fundamental Analysis & Valuation

NASDAQ:ENT

Current stock price

1.9
-0.22 (-10.38%)
At close:
1.9
0 (0%)
After Hours:

This ENT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

No Fundamental Analysis report for ENT not available.

ENT Fundamentals: All Metrics, Ratios and Statistics

Global Eagle Entrtn

NASDAQ:ENT (8/3/2020, 8:00:03 PM)

After market: 1.9 0 (0%)

1.9

-0.22 (-10.38%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners58.54%
Inst Owner Change-7.1%
Ins Owners1263.64%
Ins Owner Change0%
Market Cap7.13M
Revenue(TTM)634.42M
Net Income(TTM)-196.76M
Analysts60
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 28.87
EPS(TTM)-41.5
EYN/A
EPS(NY)-63.73
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS169
BVpS-121.43
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.21%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -14.57%
PM (TTM) -31.01%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity -0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.15
Altman-Z -4.8
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-719.33%
EPS Next Y-53.57%
EPS Next 2Y22.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.47%
Revenue growth 3YN/A
Revenue growth 5Y8.29%
Sales Q2Q%-13.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Global Eagle Entrtn / ENT Fundamental Analysis FAQ

What is the fundamental rating for ENT stock?

ChartMill assigns a fundamental rating of 2 / 10 to ENT.


Can you provide the valuation status for Global Eagle Entrtn?

ChartMill assigns a valuation rating of 0 / 10 to Global Eagle Entrtn (ENT). This can be considered as Overvalued.


What is the profitability of ENT stock?

Global Eagle Entrtn (ENT) has a profitability rating of 1 / 10.


Can you provide the financial health for ENT stock?

The financial health rating of Global Eagle Entrtn (ENT) is 2 / 10.


Is the dividend of Global Eagle Entrtn sustainable?

The dividend rating of Global Eagle Entrtn (ENT) is 0 / 10 and the dividend payout ratio is 0%.